Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si - Net Worth and Insider Trading

Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si Net Worth

The estimated net worth of Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si is at least $30 Million dollars as of 2024-06-17. Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si is the 2101 Beneficial owner of Kintor Pharmaceutical Ltd and owns about 24,873,500 shares of Kintor Pharmaceutical Ltd (HKSE:09939) stock worth over $30 Million. Details can be seen in Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si has not made any transactions after 2022-12-16 and currently still holds the listed stock(s).

Transaction Summary of Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si

Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si owns 1 companies in total, including Kintor Pharmaceutical Ltd (HKSE:09939) .

Click here to see the complete history of Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si’s form 4 insider trades.

Insider Ownership Summary of Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:09939	Kintor Pharmaceutical Ltd	2022-12-16	2101 Beneficial owner

Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si Latest Holdings Summary

Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si currently owns a total of 1 stock. Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si owns 24,873,500 shares of Kintor Pharmaceutical Ltd (HKSE:09939) as of December 16, 2022, with a value of $30 Million.

Latest Holdings of Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:09939	Kintor Pharmaceutical Ltd	2022-12-16	24,873,500	1.20	29,848,200

Holding Weightings of Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si

Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si Form 4 Trading Tracker

According to the SEC Form 4 filings, Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si has made a total of 2 transactions in Kintor Pharmaceutical Ltd (HKSE:09939) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Kintor Pharmaceutical Ltd is the sale of 0 shares on December 16, 2022, which brought Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si around $0.

Insider Trading History of Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si Ownership Network

Ownership Network List of Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si

No Data

Ownership Network Relation of Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si

Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si Owned Company Details

What does Kintor Pharmaceutical Ltd do?

Who are the key executives at Kintor Pharmaceutical Ltd?

Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si is the 2101 Beneficial owner of Kintor Pharmaceutical Ltd. Other key executives at Kintor Pharmaceutical Ltd include 2101 Beneficial owner Tong Youzhi , 2101 Beneficial owner Kt International Investment Limited , and 2201 Interest of corporation controlled by you Guo Chuangxing .

Kintor Pharmaceutical Ltd (HKSE:09939) Insider Trades Summary

Over the past 18 months, Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si made no insider transaction in Kintor Pharmaceutical Ltd (HKSE:09939). Other recent insider transactions involving Kintor Pharmaceutical Ltd (HKSE:09939) include a net sale of 0 shares made by Nomura Holdings, Inc. , a net sale of 11,530,471 shares made by Guo Chuangxing , and a net sale of 11,530,471 shares made by Kg Development Limited .

In summary, during the past 3 months, insiders sold 0 shares of Kintor Pharmaceutical Ltd (HKSE:09939) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,201,000 shares of Kintor Pharmaceutical Ltd (HKSE:09939) were sold and 2,140,058 shares were bought by its insiders, resulting in a net sale of 22,060,942 shares.

Kintor Pharmaceutical Ltd (HKSE:09939)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kintor Pharmaceutical Ltd Insider Transactions

No Available Data

Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si Mailing Address

Above is the net worth, insider trading, and ownership report for Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si. Currently GuruFocus does not have mailing address information for Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si.

Discussions on Zhu Hai Ge Li Jin Rong Tou Zi Guan Li You Xian Gong Si

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.